Effective components screening and anti-myocardial infarction mechanism study of the Chinese medicine NSLF6 based on "system to system" mode

• Main Authors: Liang Qiong-Lin, Liang Xiao-Ping, Wang Yi-Ming, Xie Yuan-Yuan, Zhang Rong-Li, Chen Xi, Gao Rong, Cheng Yi-Jun, Wu Jun, Xu Qing-Bo, Xiao Qing-Zhong, Li Xue, Lv Shu-Feng, Fan Xue-Mei, Zhang Hong-Yang, Zhang Qing-Li, Luo Guo-An
• Format: Article
• Language: English
• Published: BMC 2012-02-01
• Series: Journal of Translational Medicine
• Online Access: http://www.translational-medicine.com/content/10/1/26

<p>Abstract</p> <p>Background</p> <p><it>Shuanglong </it>formula (SLF), a Chinese medicine composed of <it>panax ginseng </it>and <it>salvia miltiorrhiza </it>exhibited significant effect in the treatment of myocardial infarction (MI) in clinical. Because of the complex nature and lack of stringent quality control, it's difficult to explain the action mechanism of SLF.</p> <p>Method</p> <p>In this study, we present a "system to system" (S2S) mode. Based on this mode, SLF was simplified successively through bioactivity-guided screening to achieve an optimized minimal phytochemical composition (new formula NSLF6) while maintaining its curative effect for MI.</p> <p>Results</p> <p>Pharmacological test combining with the study of systems biology show that NSLF6 has activity for treatment MI through synergistic therapeutic efficacies between total ginsenosides and total salvianolic acids via promoting cardiac cell regeneration and myocardial angiogenesis, antagonistic myocardial cell oxidative damage.</p> <p>Conclusions</p> <p>The present S2S mode may be an effective way for the discovery of new composite drugs from traditional medicines.</p>